Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Agilix Corporation
Advanced multiplexed protein labeling technology described
June 26th, 2004
Agilix Corporation announced that it has successfully applied its i-PROT proteomics technology to clinical samples for biomarker discovery in drug development. At a meeting of the American Society of Mass Spectrometry (ASMS) in Nashville, the company presented data on the use of i-PROT technology to find biomarkers in the serum of patients with various stages of rheumatoid arthritis. As with many diseases, early detection using protein biomarkers may allow for earlier and more effective intervention. "These findings were made possible because of the unprecedented number of labels in the i-PROT protein labeling technology - a 29 label set was...
Source: Law & Health Weekly (2004-06-26)
|
